₩6870.00
₩0.00 (0.00%)
End-of-day quote: 05/15/2024
KOSE:A009290
Kwang Dong Pharmaceutical Annual Report
| Year | Year | 2023 | 2016 | 2015 | 2013 | 2012 | 2011 | ||
|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
₩1.51T | ₩1.06T | ₩955.45B | ₩468.38B | ₩332.64B | ₩313.99B | |
| GM % | Gross Margin % |
|
19.67% | 23.24% | 24.12% | 35.94% | 40.14% | 42.99% | |
| OM | Operating Margin |
|
2.78% | 4.20% | 5.32% | 9.48% | 10.92% | 12.87% | |
| EPS | Earnings Per Share |
|
₩0.00 | ₩719.00 | ₩719.00 | ₩827.00 | ₩523.00 | ₩640.00 | ₩663.00 |
| Div. | Dividends |
|
₩80.00 | ₩80.00 | ₩80.00 | ₩70.00 | ₩0.00 | ₩0.00 | |
| PR % | Payout Ratio % |
|
11.13% | 11.13% | 9.67% | 13.38% | 0 | 0 | |
| Sha. | Shares |
|
40.08m | 40.58m | 40.58m | 41.09m | 40.81m | 42.64m | |
| OCF | Operating Cash Flow |
|
₩-11730.41M | ₩28.80B | ₩41.14B | ₩34.39B | ₩23.74B | ₩27.75B | |
| FCF | Free Cash Flow |
|
₩-18378.25M | ₩13.25B | ₩-2676.74M | ₩26.29B | ₩-7504.08M | ₩-443.18M | |
| FCFS | Free Cash Flow Per Share |
|
₩-1157.55 | ₩270.57 | ₩329.21 | ₩670.22 | ₩-180.64 | ₩-11.01 |
